top of page

Search

ATXA attends BioCapital Europe

Mar 14, 2019
1 min read

ATXA Therapeutics is attending BioCapital Europe in Amterdam today. #Lifesciences #investment

Recent Posts

Study on Structural Insights into Agonist Recognition and Function of the Thromboxane Receptor Published in Nature Communications

Study on Structural Insights into Agonist Recognition and Function of the Thromboxane Receptor Published in Nature Communications

ATXA to Attend and Present at the Pulmonary Vascular Research Institute 2026 Annual Congress

ATXA to Attend and Present at the Pulmonary Vascular Research Institute 2026 Annual Congress

ATXA Therapeutics Founder & CEO Receives 2024 NovaUCD Innovation Award

ATXA Therapeutics Founder & CEO Receives 2024 NovaUCD Innovation Award

Comments

bottom of page